Europe Antifungal Drugs Market By Drug Type (Echinocandins, Azoles, Polyenes, Allylamines, Other Drugs) By Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis, Other Therapeutic Indications) By Application (Powders, Ointments, Drugs, Pastes), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

Europe Antifungal Drugs Market By Drug Type (Echinocandins, Azoles, Polyenes, Allylamines, Other Drugs) By Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis, Other Therapeutic Indications) By Application (Powders, Ointments, Drugs, Pastes), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 246 | Pages: 145 | October 2018 | Region: Europe


Antifungal drugs are used commonly for curing fungal infections occurring due to, unclean, unhygienic and damp environment. Invasion of epithelial tissue by microscopic organisms lead to fungal infections. Systemic fungal infections are those caused due to indigestion or inhalation of spores, leading to fungal pneumonia and diseases like candidaisis, meningitis, mucormycosis, etc. are caused by opportunistic fungus. Although majority of the fungal infections and diseases are commonly non-lethal, they are very uncomforting to the host and their common occurrence is responsible for the rising antifungal drugs market. Antifungal drugs work via various mechanisms such as by inhibiting of cell wall formation, cell membrane disruption and cell division.

The major factors that are driving the market are increasing awareness of fungal infections with the growing incidence rate of antifungal infections all over the world, increasing government and corporate funds in the industry. And also the development of public private partnership in the pharmaceutical industry, the rising popularity of over-the-counter antifungal drugs for dermal infections are vastly responsible for the growing antifungal drugs market size. Also, the rising population having weak immune system, in whom the occurrence of fungal infections is much more than average, will drive the market. High prevalence of conventional drugs used for the treatment of fungal infections is significantly restraining the market growth. Cost of drugs and their effectiveness in treatments remain as the challenges for the market

Europe Antifungal Drugs Market is estimated at $3.4 billion in 2018 and projected to grow with CAGR of 3.4% reaching $4.01 billion by 2023. In the following few years, the market is poised to grow hugely with the rising population globally.

The antifungal drugs market is segmented on the basis of drug type into 1. Echinocandins, 2. Azoles, 3. Polyenes, 4. Allylamines and 5. Other Drugs, by type of therapeutic indications into 1. Aspergillosis, 2. Dermatophytosis, 3. Candidiasis and 4. Other therapeutic indications, by applications into 1. Powders, 2. Ointments, 3. Drugs and 4. Pastes. While Azoles (fluconazole, itraconazole, ketoconazole, posaconazole and voriconazole) are systemically acting, Echinocandins (anidulafungin, caspofungin and micafungin) are lipopeptides derived from natural fungal fermentation products and Polyenes (amphotericin B deoxycholate and liposomal amphotericin B. Corifungin) are systemically acting and disrupt eukaryotic cellular membranes. Azoles Antifungal Drugs segment is the largest segment of the market followed by echinocandins.

Based on geography, the Europe antifungal drugs market is sub-segmented into U.K., Spain, Germany, Italy and France. Europe commands second largest share of the global antifungal drugs market next to North America. Germany contributes to the major share of the Europe antifungal drugs market. Growing technological advancements in the Europe region will drive the market.

Alternaria, Pfizer, Novartis, Sanofi-Aventis, Merck & Co., Asperqillus, Kramer Laboratories, Bayer Healthcare, Enzon Pharmaceuticals, Glaxosmithkline Gilead and Abbott Laboratories are some of the major market leaders.

1.Introduction                                  

            1.1 Market Definition                      

            1.2 Study Deliverables                     

            1.3 Base Currency, Base Year and Forecast Periods                    

            1.4 General Study Assumptions                

2. Research Methodology                           

            2.1 Introduction                   

            2.2 Research Phases            

                        2.2.1 Secondary Research   

                        2.2.2 Primary Research       

                        2.2.3 Econometric Modelling         

                        2.2.4 Expert Validation        

            2.3 Analysis Design              

            2.4 Study Timeline               

3. Overview                           

            3.1 Executive Summary                   

            3.2 Key Inferences                

            3.3 New Developments                   

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                        

            4.1 Market Drivers               

            4.2 Market Restraints                     

            4.3 Key Challenges               

            4.4 Current Opportunities in the Market             

5. Market Segmentation                             

            5.1 By Drug Type                  

                        5.1.1 Echinocandins 

                        5.1.2 Azoles  

                        5.1.3 Polyenes          

                        5.1.4 Allylamines     

                        5.1.5 Others  

            5.2 By Therapeutic Indications                   

                        5.2.1 Aspergillosis    

                        5.2.2 Dermatophytosis       

                        5.2.3 Candidiasis      

                        5.2.4 Others  

            5.3 By Application                

                        5.3.1 Powders          

                        5.3.2 Ointments       

                        5.3.5 Drugs   

                        5.3.4 Pastes  

6. Geographical Analysis                             

            6.1 Europe                

                        6.1.1 Introduction    

                        6.1.2 U.K       

                        6.1.3 Spain    

                        6.1.4 Germany         

                        6.1.5 Italy      

                        6.1.6 France            

7.Strategic Analysis                         

            7.1 PESTLE analysis              

                        7.1.1 Political

                        7.1.2 Economic         

                        7.1.3 Social   

                        7.1.4 Technological  

                        7.1.5 Legal     

                        7.1.6 Environmental

            7.2 Porter’s Five analysis                

                        7.2.1 Bargaining Power of Suppliers          

                        7.2.2 Bargaining Power of Consumers      

                        7.2.3 Threat of New Entrants         

                        7.2.4 Threat of Substitute Products and Services

                        7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                         

            8.1 Alternaria                       

                        8.1.1 Overview         

                        8.1.2 Product Analysis        

                        8.1.3 Strategic Evaluation and Operations           

                        8.1.4 Financial analysis       

                        8.1.5 Legal issues     

                        8.1.6 Recent Developments

                        8.1.7 SWOT analysis

                        8.1.8 Analyst View   

            8.2 Pfizer                   

            8.3 Novartis              

            8.4 Sanofi-Aventis                

            8.5 Merck & Co.                   

            8.6 Asperqillus                     

            8.7 Kramer Laboratories                 

            8.8 Bayer Healthcare                       

            8.9 Enzon Pharmaceuticals             

            8.10 Glaxosmithkline Gilead                      

            8.11 Abbott Laboratories               

9.Competitive Landscape                            

            9.1 Market share analysis               

            9.2 Merger and Acquisition Analysis                     

            9.3 Agreements, collaborations and Joint Ventures                   

            9.4 New Product Launches             

10.Expert Opinions                          

            10.1 Market Outlook                       

            10.2 Investment Opportunities                 

Appendix                               

            a) List of Tables                    

               b) List of Figures       

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Antifungal Drugs Market By Region, From 2018-2023(USD Million)
  2. Europe Antifungal Drugs Market By Drug Type, From 2018-2023(USD Million)
  3. Europe Echinocandins Market By Region, From 2018-2023(USD Million)
  4. Europe Azoles Market By Region, From 2018-2023(USD Million)
  5. Europe Polyenes Market By Region, From 2018-2023(USD Million)
  6. Europe Allylamines Market By Region, From 2018-2023(USD Million)
  7. Europe Other Drugs Market By Region, From 2018-2023(USD Million)
  8. Europe Antifungal Drugs Market By Therapeutic Indications, From 2018-2023(USD Million)
  9. Europe Aspergillosis Market By Region, From 2018-2023(USD Million)
  10. Europe Dermatophytosis Market By Region, From 2018-2023(USD Million)
  11. Europe Candidiasis Market By Region, From 2018-2023(USD Million)
  12. Europe Other Therapeutic Indications Market By Region, From 2018-2023(USD Million)
  13. Europe Antifungal Drugs Market By Application, From 2018-2023(USD Million)
  14. Europe Powders Market By Region, From 2018-2023(USD Million)
  15. Europe Ointments Market By Region, From 2018-2023(USD Million)
  16. Europe Drugs Market By Region, From 2018-2023(USD Million)
  17. Europe Pastes Market By Region, From 2018-2023(USD Million)
  18. U.K Antifungal Drugs Market By Drug Type, From 2018-2023(USD Million)
  19. U.K Antifungal Drugs Market By Therapeutic Indications, From 2018-2023(USD Million)
  20. U.K Antifungal Drugs Market By Application, From 2018-2023(USD Million)
  21. Spain Antifungal Drugs Market By Drug Type, From 2018-2023(USD Million)
  22. Spain Antifungal Drugs Market By Therapeutic Indications, From 2018-2023(USD Million)
  23. Spain Antifungal Drugs Market By Application, From 2018-2023(USD Million)
  24. Germany Antifungal Drugs Market By Drug Type, From 2018-2023(USD Million)
  25. Germany Antifungal Drugs Market By Therapeutic Indications, From 2018-2023(USD Million)
  26. Germany Antifungal Drugs Market By Application, From 2018-2023(USD Million)
  27. Italy Antifungal Drugs Market By Drug Type, From 2018-2023(USD Million)
  28. Italy Antifungal Drugs Market By Therapeutic Indications, From 2018-2023(USD Million)
  29. Italy Antifungal Drugs Market By Application, From 2018-2023(USD Million)
  30. France Antifungal Drugs Market By Drug Type, From 2018-2023(USD Million)
  31. France Antifungal Drugs Market By Therapeutic Indications, From 2018-2023(USD Million)
  32. France Antifungal Drugs Market By Application, From 2018-2023(USD Million)
Middle East And Africa Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth...
Asia Pacific Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, A...
Europe Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Fo...
North America Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, ...
Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts ...
Middle East And Africa Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) A...
Latin America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Asia Pacific Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Regi...
Europe Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - I...
North America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - Industry...
Pharmaceutical Gelatin Market By Function (stabilizers, Thickeners, Gelling Agents And Others) , By Source( Pig Skin, Bovine Hides, Bones And Others), By Application ( Hard Capsules, Soft Capsules, Microencapsulatio...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.